Latest News

Release of DARRT-1 Preliminary Safety Data
Pre-Clinical data confirms Radio-Enhancing potential
Noxopharm Corporate Presentation for Public Briefing
End-of-Study Clinical Data shows benefit of NOX66
NOX to present at American Society of Clinical Oncology
Noxopharm 2018 Mid-Year Investor Briefings
NOX CEO interview updates the company's current R&D program
NOX CEO interview on near complete NOX66 chemotherapy trial
NOX CEO interview on Radiotherapy Clinical Programs
St Vincent's Hospital study passes first milestone